Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2003 Aug;5(1-2):31-44.

How does HIV-1 infect a susceptible human cell?: Current thinking

Affiliations
Review

How does HIV-1 infect a susceptible human cell?: Current thinking

Ali A Al-Jabri. J Sci Res Med Sci. 2003 Aug.

Abstract

To insure its survival, the human immunodeficiency virus (HIV), the causative agent of acquired immunodeficiency syndrome (AIDS), utilises more than one gate to enter a target cell. This strategy makes it more difficult for the immune system to defeat the virus. This has also made it difficult for scientists working in the HIV research to understand how exactly HIV infects a susceptible human cell. Such understanding will no doubt open many gates for scientists to vanquish the virus by designing agents that can block HIV entry into target cells, thus rendering the virus vulnerable to immune destruction. This will also help in understanding the replication of the virus and the pathogenesis of the disease. The present article briefly describes the past and current thinking of how HIV-1 infects a susceptible human cell, and the dilemma scientists are facing when studying the infectivity of this virus and applying current knowledge to design agents that can block HIVs entering target cells. In the context of our own experience with HIV infectivity in vitro, the present article will also address the behaviour of different HIV isolates, both laboratory-adopted and clinical (primary) isolates in culture and the difficulties in performing HIV infectivity testing. Moreover, our experience of peripheral blood mononuclear cells' (PBMCs) susceptibility to HIVs infection in vitro is discussed.

Keywords: AIDS; HIV; immune; infection; susceptible cell; virus.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Electron micrograph of HIV-1 and HIV-2 (MN and ROD). HIV-1 (MN) virions are shown budding (arrow). HIV-2 (ROD) virions are shown in (b) (above). Magnification is 100,000 x. Scale bar =100nm. This electron microscopy was kindly performed by Dr. Robert Dourmashkin.
Figure 1b
Figure 1b
Simple diagram illustrating the main components of the basic structure of HIV-1.
Figure 2
Figure 2
The life cycle of HIVs
Figure 3a
Figure 3a
Normal healthy H9 cells.
Figure 3b
Figure 3b
Cytopathic effects of HIV-1 infection in vitro, using H9 cells (syncytia formation)

Similar articles

Cited by

References

    1. Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, Wolf RA, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med. 1981;305:1425–1431. - PubMed
    1. Masur H, Michelis MA, Greene JB, Onorata I, Vande Stouwe RA, Holzman RS, et al. An outbreak of community-acquired Pneumocystis carinii pneumonia. N Engl J Med. 1981;305:1431–1438. - PubMed
    1. Centers for Disease Control and Prevention. Revised classification system for HIV infection and expanded surveillance of definition for AIDS among adolescents and adults. MMWR. 1993;41:17. - PubMed
    1. Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Ann Intern Med. 2002;137:381–433. - PubMed
    1. Barre-Sinoussi F, Chermann JC, Rey R, Nugeyre MT, Chamaret S, Gruest J, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS) Science. 1983;220:868–871. - PubMed

LinkOut - more resources